TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05952804: IVIG for Infection Prevention After CAR-T-Cell Therapy

Sponsor: Fred Hutchinson Cancer Center · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 150 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$970,200

Rescue Site Savings

+$646,800

Unlock Full NCT05952804 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05952804 Rescue Dossier →